Clinical Practice Guidelines

National Clinical Guidelines

The Cancer Strategy 2006 recommended that national site-specific multi-disciplinary groups should be convened to develop evidence based guidelines for common cancers.

Evidence-based guidelines:

• Aim to improve the quality of clinical care
• Aim to prevent variation in practice
• Are based on the best research evidence in conjunction with clinical expertise

The National Cancer Control Programme (NCCP) is developing national evidence-based clinical guidelines for the diagnosis, staging and treatment of common cancers, through its "Guideline Development Groups" commencing with:

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Gestational Trophoblastic Disease
• Ovarian Cancer
• Oesophageal Cancer
• Colon Cancer
• Rectal Cancer

Consensus statement

• Colon, Rectal and Anal Cancer Surveillance Recommendations Consensus group statement

Evidence into practice - rapid reviews

• Systemic anti-cancer treatment of patients with metastatic melanoma

COVID-19 Guidance is available here

The NCCP have developed a number of guidance documents that are available here and in the HSE COVID-19 Clinical Guidance and Evidence Repository.

Last updated 09th March 2023